AHA GUIDELINES Bundle (free trial)

Hypertrophic Cardiomyopathy 2024

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1521559

Contents of this Issue

Navigation

Page 33 of 43

34 Treatment Figure 5. Heart Failure Algorithm Patients With HCM LVEF <50% and LBBB YES NO Systolic function LVEF <50% LVEF ≥50% Obstructive physiology? Continue current management (1) YES NO YES Evaluate for heart transplant (1) NYHA class III-IV Symptoms after CRT NO NYHA class I-II NYHA class III-IV Discontinue negative inotropic agents (verapamil, diltiazem, disopyramide) (2a) GDMT per Heart Failure Guideline (1) ICD (2a) Interrupt or discontinue myosin inhibitor (1) Evaluate for other causes of reduced EF (1) CRT (2a)

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - Hypertrophic Cardiomyopathy 2024